PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)
China · Delayed Price · Currency is CNY 41.14
+0.99 (2.47%)
Feb 3, 2026, 3:04 PM CST
SHE:300725 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 201.14 | 219.54 | 197.36 | 314.22 | 486.56 | 184.21 |
Depreciation & Amortization | 131.2 | 131.2 | 116.09 | 88.03 | 54.99 | 24.47 |
Other Amortization | 7.95 | 7.95 | 5.49 | 6.44 | 3.83 | 1.71 |
Loss (Gain) From Sale of Assets | - | - | -0.42 | - | -0.04 | - |
Asset Writedown & Restructuring Costs | 1.41 | 1.41 | 14.8 | 20.68 | 10.41 | 7.31 |
Loss (Gain) From Sale of Investments | -36.46 | -36.46 | 7.27 | -19.89 | -238.15 | -2.61 |
Provision & Write-off of Bad Debts | 3.9 | 3.9 | 9.83 | - | - | - |
Other Operating Activities | 463.38 | 90.38 | 94.79 | 28.2 | 43.31 | 24.27 |
Change in Accounts Receivable | -60.11 | -60.11 | 37.37 | -31.42 | -133.74 | -100.9 |
Change in Inventory | -175.24 | -175.24 | -74.74 | -237.66 | -51.77 | -107.82 |
Change in Accounts Payable | 116.81 | 116.81 | -177.78 | 66.19 | 41.78 | 199.71 |
Change in Other Net Operating Assets | -0.35 | -0.35 | 15.41 | 24.95 | 32.24 | 48.59 |
Operating Cash Flow | 657.43 | 302.82 | 246.84 | 246.61 | 238.03 | 271.51 |
Operating Cash Flow Growth | 128.95% | 22.68% | 0.09% | 3.60% | -12.33% | 113.71% |
Capital Expenditures | -102.43 | -118.12 | -315.77 | -557.91 | -505.76 | -75.18 |
Sale of Property, Plant & Equipment | -0.11 | 0.01 | 2.1 | 0.28 | 0.2 | 0.02 |
Cash Acquisitions | - | - | - | - | -152.59 | - |
Investment in Securities | -303.66 | 6.54 | -626.5 | -56.04 | -276.14 | -71.6 |
Other Investing Activities | 28.38 | 35.47 | -3.61 | 20.03 | 19.94 | 2.18 |
Investing Cash Flow | -377.83 | -76.11 | -943.78 | -593.64 | -914.34 | -144.58 |
Long-Term Debt Issued | - | 250.01 | 466.48 | 1,998 | 290.58 | 150.88 |
Total Debt Issued | 100 | 250.01 | 466.48 | 1,998 | 290.58 | 150.88 |
Short-Term Debt Repaid | - | - | - | -31.52 | - | - |
Long-Term Debt Repaid | - | -630.99 | -339.39 | -708.15 | -122.98 | -90.87 |
Total Debt Repaid | -367.23 | -630.99 | -339.39 | -739.67 | -122.98 | -90.87 |
Net Debt Issued (Repaid) | -267.23 | -380.98 | 127.1 | 1,258 | 167.6 | 60.01 |
Issuance of Common Stock | - | - | - | - | - | 955.63 |
Repurchase of Common Stock | -10.01 | -10.01 | -20.03 | -1.02 | - | - |
Common Dividends Paid | -70.75 | -77.97 | -41.69 | -33.67 | -22.38 | -21.66 |
Other Financing Activities | 8.94 | - | - | -463.07 | - | -1.32 |
Financing Cash Flow | -339.05 | -468.96 | 65.37 | 760.36 | 145.22 | 992.67 |
Foreign Exchange Rate Adjustments | 27.46 | 24.17 | 1.89 | 31.99 | -17 | -23.45 |
Net Cash Flow | -31.99 | -218.07 | -629.68 | 445.33 | -548.09 | 1,096 |
Free Cash Flow | 555 | 184.7 | -68.93 | -311.3 | -267.73 | 196.33 |
Free Cash Flow Growth | 188.55% | - | - | - | - | - |
Free Cash Flow Margin | 28.03% | 10.94% | -4.00% | -19.52% | -22.28% | 19.21% |
Free Cash Flow Per Share | 2.76 | 0.93 | -0.34 | -1.55 | -1.34 | 1.04 |
Cash Interest Paid | - | - | - | - | - | 0.63 |
Cash Income Tax Paid | 43.5 | 50.85 | -24.08 | -39.23 | 4.77 | -12.88 |
Levered Free Cash Flow | 517.77 | 18.06 | -344.25 | -508.34 | -379.49 | 84.92 |
Unlevered Free Cash Flow | 549.53 | 56.13 | -302.94 | -479.76 | -373.75 | 85.31 |
Change in Working Capital | -115.1 | -115.1 | -198.38 | -191.08 | -122.88 | 32.14 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.